DURATION-2 Study Group
All authors
About
Publications While At HealthPartners
selected publications
Journal Article
Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial
.
Lancet (London, England).
2010
Contact
full name
DURATION-2 Study Group
Quick Info
Publications
Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
Collaboration
Co-author network
Map of science
Referenced in
2
policy sources
Referenced in
1
clinical guideline sources
331
readers on Mendeley
3
readers on CiteULike
See more details
